Drug class
Benzodiazepine anxiolytic; GABAA-receptor positive allosteric modulator
Mechanism of action
Binds to the benzodiazepine site on GABAA receptors and enhances the inhibitory effect of GABA, increasing chloride-channel opening frequency and reducing neuronal excitability.
General use cases
- Short-term symptomatic treatment of severe anxiety in adults when symptoms are disabling or cause significant distress, in countries where bromazepam is authorised; prolonged use is discouraged because of tolerance and dependence risks
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
